Home / Services / Diabetic Kidney Disease
Diabetic Nephropathy Care

Diabetic Kidney Disease

Protecting renal function in diabetes through modern evidence-based medical protocols (SGLT2i, Finerenone, GLP-1 RA, and BP control).

Diabetic Kidney Disease - Dr. Vishal Singh Swasth Kidney Clinic
31+
Years Experience
10,000+
Diabetic Patients Treated
40%
Diabetics at Risk
Early
Screening Saves Kidneys

Comprehensive Care & Management

Diabetic Kidney Disease (DKD), also known as diabetic nephropathy, is the leading cause of chronic kidney disease and end-stage renal failure worldwide. Up to 40% of individuals with long-standing Type 1 or Type 2 diabetes develop kidney damage due to microvascular capillary injury caused by persistent high blood sugar.

At Swasth Kidney Clinic, Dr. Vishal Singh emphasizes early detection through annual microalbuminuria screening and proactive renal-protective treatment. By integrating modern breakthroughs — such as SGLT2 inhibitors (Empagliflozin/Dapagliflozin), non-steroidal MRAs (Finerenone), GLP-1 receptor agonists, and RAAS inhibitors — we effectively halt or significantly slow kidney decline in diabetic patients.

What We Treat
  • Microalbuminuria (Early Urine Protein Leakage)
  • Overt Diabetic Nephropathy & Macroalbuminuria
  • Diabetic Chronic Kidney Disease (Stages 1 to 5)
  • Combined Diabetic & Hypertensive Renal Disease
  • Resistant Hypertension in Diabetic Patients
  • Metabolic & Cardiovascular Risk Optimization in DKD
Who Should Consult Us
  • All Type 2 diabetic patients (annually from time of diagnosis)
  • Type 1 diabetics diagnosed for 5 or more years
  • Diabetic patients with foamy urine or elevated creatinine
  • Diabetics struggling to control high blood pressure (>130/80 mmHg)
  • Diabetic patients with swelling in legs, ankles, or feet

How We Care For You

A structured, compassionate approach from initial consultation through diagnosis, specialized therapy, and long-term surveillance.

01
Annual Screening & Biomarkers
Urine Albumin-to-Creatinine Ratio (uACR) test paired with serum creatinine eGFR calculation.
02
Comprehensive Risk Assessment
Evaluation of HbA1c, ambulatory blood pressure profile, lipid panels, and cardiovascular risk factors.
03
Multi-Drug Renal Protection
Prescription of kidney-protective SGLT2 inhibitors, Finerenone, ACEi/ARBs, and individualized glucose targets.
04
Proactive Follow-up
Quarterly lab surveillance to track protein reduction, preserve glomerular filtration, and prevent complications.

Conditions We Manage

Personalized diagnostic and treatment pathways addressing specific stages and variations of kidney disease.

Icon
Microalbuminuria (Stage 1)
Urine ACR 30–300 mg/g; the golden window where kidney damage can be halted or reversed.
Icon
Overt Proteinuria (Macroalbuminuria)
Urine ACR >300 mg/g; indicates established glomerular capillary damage requiring aggressive therapy.
Icon
Diabetic CKD Stage 3–4
Declining eGFR; requires careful dose adjustments of diabetic medications (e.g., Metformin/Sulphonylureas).
Icon
Renal Hypertension in Diabetes
Intractable blood pressure driven by fluid retention and arterial stiffness; managed with targeted combination therapy.
Icon
Hyperkalaemia in Diabetic CKD
Elevated blood potassium that complicates heart/kidney medication; managed with novel potassium binders.
Icon
Pre-Transplant Diabetic Care
Pre-emptive evaluation for living donor kidney transplant before dialysis is required.

Renowned Clinical Leadership

With 31+ years of nephrology practice, military leadership, and academic fellowships, Dr. Vishal Singh delivers world-class, compassionate kidney care.

01
Academic & Clinical Authority
MBBS (AFMC Pune), MD, DNB, DrNB Nephrology, FASN (USA), FRCP (Edinburgh), FISN. Former Professor & HOD at Army Hospital (R&R), Delhi.
02
Pioneering Transplant Expertise
Over 1,000 kidney transplants performed — including blood group incompatible (ABOi), sensitized host, paediatric, and deceased donor transplants.
03
Evidence-Based Protocols
Implementation of modern guideline-directed therapies (SGLT2i, Finerenone, online HDF) backed by clinical evidence to maximize kidney longevity.
04
Full Procedural Suite
Access to complete interventional nephrology: ultrasound-guided renal biopsies, AV fistula creation, permcath insertion, and PD catheter placement.
05
Director & Unit Head at Max Hospital
Seamless continuity between outpatient clinic care at Greater Noida and advanced tertiary hospital facilities at Max Super Specialty Hospital, Vaishali.
06
Patient-Centred Philosophy
Transparent counselling, dietary and lifestyle education, and compassionate support tailored to every patient and their family.

Frequently Asked Questions

Get clear, medically verified answers about diagnosis, treatment options, and disease progression.

Can Diabetic Kidney Disease be prevented?
+
Yes! Regular annual screening for microalbuminuria, keeping HbA1c near 7%, controlling blood pressure strictly below 130/80 mmHg, and starting kidney-protective drugs (SGLT2 inhibitors and ARBs) early can prevent or postpone diabetic kidney failure.
How do SGLT2 inhibitors protect the kidneys?
+
SGLT2 inhibitors (such as Dapagliflozin and Empagliflozin) reduce intraglomerular pressure, decrease proteinuria, reduce inflammation, and have been proven in major clinical trials to reduce the risk of kidney failure by up to 40%.
Can I take Metformin if I have kidney disease?
+
Metformin is safe in early to moderate kidney disease, but its dosage must be reduced when eGFR falls below 45 mL/min, and discontinued when eGFR is below 30 mL/min to prevent lactic acidosis. Dr. Singh tailors all diabetes medications to your renal status.
Why does my urine look foamy or frothy?
+
Foamy urine is a classic sign of protein (albumin) leaking through damaged kidney filtration barriers into the urine. If you have diabetes and notice frothy urine, consult Dr. Vishal Singh immediately.
Take the first step toward better kidney health today.

Consult Dr. Vishal Singh at Swasth Kidney Clinic, Greater Noida or Max Hospital, Vaishali.

Book Appointment
Chat with us